肠道菌群
疾病
免疫系统
免疫调节
机制(生物学)
生物信息学
炎症性肠病
计算生物学
神经科学
医学
生物
免疫学
哲学
认识论
病理
作者
Mu‐Qing Li,Lulu Wang,Demin Lin,Zihan Liu,Hongliang Wang,Yanfang Yang,Chunmeng Sun,Jun Ye,Yuling Liu
出处
期刊:ACS Nano
[American Chemical Society]
日期:2024-07-31
卷期号:18 (32): 20886-20933
被引量:1
标识
DOI:10.1021/acsnano.4c05013
摘要
Gut microbiota plays a crucial role in maintaining host homeostasis, impacting the progression and therapeutic outcomes of diseases, including inflammatory bowel disease, cancer, hepatic conditions, obesity, cardiovascular pathologies, and neurologic disorders, via immune, neural, and metabolic mechanisms. Hence, the gut microbiota is a promising target for disease therapy. The safety and precision of traditional microbiota regulation methods remain a challenge, which limits their widespread clinical application. This limitation has catalyzed a shift toward the development of multifunctional delivery systems that are predicated on microbiota modulation. Guided by bioinspired strategies, an extensive variety of naturally occurring materials and mechanisms have been emulated and harnessed for the construction of platforms aimed at the monitoring and modulation of gut microbiota. This review outlines the strategies and advantages of utilizing bioinspired principles in the design of gut microbiota intervention systems based on traditional regulation methods. Representative studies on the development of bioinspired therapeutic platforms are summarized, which are based on gut microbiota modulation to confer multiple pharmacological benefits for the synergistic management of diseases. The prospective avenues and inherent challenges associated with the adoption of bioinspired strategies in the refinement of gut microbiota modulation platforms are proposed to augment the efficacy of disease treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI